Reviva Pharmaceuticals (Nasdaq: RVPH), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, announced over 80% of patients have been enrolled in the pivotal Phase 3 RECOVER study evaluating brilaroxazine for the treatment of schizophrenia. Enrollment is ongoing at multiple sites in the United States, Europe, and Asia.

Aridis Pharmaceuticals (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, announced that its AR-301 clinical program has been deemed eligible for consideration under the U.S. Food and Drug Administration’s (FDA) Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD). The FDA's agreement signifies that the AR-301 clinical program meets the requirements for a well-defined limited population with unmet medical need as designated in the LPAD guidance.

Graphex Group Limited, together with its wholly owned US subsidiary, Graphex Technologies, LLC (“Graphex” or the “Company”) (NYSE American: GRFX | HKSE: 6128), a multinational technology company focused on the development of technologies and products to enhance renewable energy, announced that it has engaged the services of New York City-based investment bank and financial advisory firm, Maxim Group LLC ("Maxim"). Maxim will provide financial advisory services in relation to the potential spinoff of Graphex Technologies, LLC. The terms and conditions of any spinoff will be determined after analysis by Maxim.

QYOU Media (OTCQB: QYOU), a company operating in India and the United States producing and distributing content created by social media stars and digital content creators,  announced that Indian digital leader and strategist, Raj Mishra, has been added as a Nominee to join the Board of Directors of QYOU Media at the company's shareholder meeting slated for July 17, 2023.  In addition, Mishra will immediately begin an assignment to provide strategic advisory services to the company, principally surrounding new product launches into the direct to consumer market in India.